v3.21.2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net Sales $ 4,136 $ 2,501 $ 12,273 $ 6,488
Cost of Sales (includes inventory write-downs of $2,400 and $2,400 during the three and nine months ended September 30, 2020, respectively) 3,170 5,200 10,398 10,058
Gross profit (loss) 966 (2,699) 1,875 (3,570)
Operating Expenses        
Sales and marketing 372 445 1,119 1,296
Research and development 533 489 1,485 1,309
General and administrative 823 1,080 2,796 3,154
Total operating expenses 1,728 2,014 5,400 5,759
Loss from operations (762) (4,713) (3,525) (9,329)
Other income (expenses)        
Interest expense and finance costs (14) (11) (46) (46)
Gain on forgiveness of PPP loan payable 1,715 1,715
Other income (expense), net 3 1 29 14
Total other income (expenses), net 1,704 (10) 1,698 (32)
Income (loss) before income taxes 942 (4,723) (1,827) (9,361)
Income tax benefit        
Current (1,484)
Deferred (655)
Total income tax benefit (2,139)
Net income (loss) $ 942 $ (4,723) $ (1,827) $ (7,222)
Net income (loss) per share – basic $ 0.07 $ (0.42) $ (0.14) $ (0.68)
Net income (loss) per share – dilutive $ 0.07 $ (0.42) $ (0.14) $ (0.68)
Weighted average shares outstanding, basic 12,788,203 11,315,984 12,697,683 10,659,308
Weighted average shares outstanding, dilutive 12,807,361 11,315,984 12,697,683 10,659,308

Source